1. Home
  2. FRST vs STRO Comparison

FRST vs STRO Comparison

Compare FRST & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primis Financial Corp.

FRST

Primis Financial Corp.

HOLD

Current Price

$14.35

Market Cap

342.4M

Sector

Finance

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$26.03

Market Cap

524.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRST
STRO
Founded
2004
2003
Country
United States
United States
Employees
N/A
133
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
342.4M
524.8M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
FRST
STRO
Price
$14.35
$26.03
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$31.33
AVG Volume (30 Days)
241.2K
255.3K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
2.74%
N/A
EPS Growth
477.27
N/A
EPS
0.30
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.63
N/A
P/E Ratio
$47.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.25
$0.67
52 Week High
$14.97
$43.85

Technical Indicators

Market Signals
Indicator
FRST
STRO
Relative Strength Index (RSI) 54.42 30.61
Support Level $13.71 $23.43
Resistance Level $14.45 $27.96
Average True Range (ATR) 0.28 3.47
MACD -0.03 -1.79
Stochastic Oscillator 53.70 0.40

Price Performance

Historical Comparison
FRST
STRO

About FRST Primis Financial Corp.

Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. The company has two reportable segments: Primis Bank. This segment specializes in providing financing services to businesses in various industries along with consumer and residential loans to individuals. Primis Mortgage. This segment specializes in originating mortgages in a majority of the U.S. The revenue is from Primis Bank.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: